Status:
COMPLETED
Improving Hepatitis C Treatment in Injection Drug Users
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Hepatitis C
Liver Diseases
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The overall goal of the research project is to improve the outcome of medical care for injection drug users (IDUs) with Hepatitis C viral (HCV) infection. Hypothesis: An intervention designed to impr...
Detailed Description
The overall goal of the proposed health services research project is to improve the outcome of medical care for injection drug users (IDUs) with Hepatitis C viral (HCV) infection. This will be done by...
Eligibility Criteria
Inclusion
- 18-65 years of age.
- Enrolled in outpatient methadone maintenance treatment for greater than 3 months.
- Hepatitis C RNA positive.
- Willingness to accept HCV treatment.
- Subject has non-VA (Veteran's Administration) medical insurance or is willing to bear any and all expenses associated with Hepatitis C medical treatment.
Exclusion
- In need of inpatient drug or alcohol detoxification.
- Currently receiving the standard Hepatitis C treatment
- Unable to give adequate informed consent.
- Pregnant, nursing, or planning to become pregnant during HCV treatment or within 6 months following completion of treatment.
- Male subject who has a female sexual partner who is pregnant or planning to become pregnant at any time during HCV treatment or within 6 months following completion of treatment.
- Female subject or male subject who has a female sexual partner who is of child bearing years and not using two medically approved forms of contraception.
- Subject has made a commitment to attend residential care psychiatric or drug/alcohol rehabilitation, which would lead to unavailability to attend regularly scheduled medical care and research visits.
- Subject did not attend all required screening appointments.
- Subject has a legal proceeding whose outcome may lead to incarceration within 3 months of intake.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT00148031
Start Date
September 1 2003
End Date
March 1 2007
Last Update
April 24 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Crouse Chemical Dependency Treatment Services
Syracuse, New York, United States, 13210
2
SUNY Upstate Medical University - Department of Gastroenterology
Syracuse, New York, United States, 13210